VolitionRx Limited (VNRX) Q2 FY25 Earnings Call

Q2 FY25 results, source: company transcript and SEC filings
QuarterQ2 FY25
Call date2025-08-15
Length48 minutes
EPS$-0.06
EPS consensus$-0.05
Revenue$406688.00

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

Other quarters: Q2 FY26 · Q4 FY25 · Q1 FY25

All VNRX earnings · Back to VNRX overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.